Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA CodeGlobeNewsWire • 02/07/24
Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)Seeking Alpha • 01/31/24
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and IndiaGlobeNewsWire • 01/31/24
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.GlobeNewsWire • 01/31/24
Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to KenyaGlobeNewsWire • 12/27/23
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held SharesGlobeNewsWire • 11/28/23
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial ResultsGlobeNewsWire • 09/27/23
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price RequirementGlobeNewsWire • 09/11/23
Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution SystemGlobeNewsWire • 08/07/23
Trinity Biotech plc to Announce First Quarter Fiscal Year 2023 Financial ResultsGlobeNewsWire • 07/03/23
Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to BiosynthGlobeNewsWire • 04/27/23
Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to BiosynthGlobeNewsWire • 04/20/23
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial ResultsGlobeNewsWire • 03/23/23
Trinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Kenyan HIV Testing AlgorithmGlobeNewsWire • 03/22/23